KEGG   COMPOUND: C00041
Entry
C00041                      Compound                               

Name
L-Alanine;
L-2-Aminopropionic acid;
L-alpha-Alanine
Formula
C3H7NO2
Exact mass
89.0477
Mol weight
89.0932
Structure
Remark
Same as: D00012
Reaction
Pathway
map00250  Alanine, aspartate and glutamate metabolism
map00270  Cysteine and methionine metabolism
map00430  Taurine and hypotaurine metabolism
map00450  Selenocompound metabolism
map00473  D-Alanine metabolism
map00710  Carbon fixation in photosynthetic organisms
map00970  Aminoacyl-tRNA biosynthesis
map00998  Biosynthesis of various secondary metabolites - part 2
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01230  Biosynthesis of amino acids
map01502  Vancomycin resistance
map02010  ABC transporters
map04122  Sulfur relay system
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00171  C4-dicarboxylic acid cycle, NAD - malic enzyme type
M00901  Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline
Enzyme
1.4.1.1         1.5.1.17        2.3.1.47        2.6.1.2         
2.6.1.12        2.6.1.15        2.6.1.18        2.6.1.30        
2.6.1.37        2.6.1.40        2.6.1.41        2.6.1.43        
2.6.1.44        2.6.1.46        2.6.1.47        2.6.1.51        
2.6.1.56        2.6.1.58        2.6.1.66        2.6.1.71        
2.6.1.77        2.6.1.84        2.6.1.96        2.6.1.99        
2.6.1.108       2.6.1.113       2.6.1.115       2.6.1.119       
2.8.1.7         2.8.1.9         3.5.1.28        3.7.1.3         
4.1.1.12        4.1.1.64        4.4.1.16        5.1.1.1         
6.1.1.7         6.3.2.8         6.3.2.49        6.3.2.-
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00041  Alanine (Ala)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Alanine
    D00012  Alanine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00012  L-Alanine
Other DBs
CAS: 56-41-7
PubChem: 3343
ChEBI: 16977
ChEMBL: CHEMBL279597
KNApSAcK: C00001332
PDB-CCD: ALA[PDBj]
3DMET: B00011
NIKKAJI: J9.168E
KCF data

ATOM        6
            1   O6a O    22.7503  -15.7507
            2   C6a C    23.9627  -15.0506
            3   C1c C    25.1753  -15.7507
            4   C1a C    26.3878  -15.0506
            5   O6a O    23.9627  -13.6508
            6   N1a N    25.1753  -17.1506
BOND        5
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     2   5 2
            5     3   6 1 #Down

» Japanese version

KEGG   COMPOUND: C00065
Entry
C00065                      Compound                               

Name
L-Serine;
L-2-Amino-3-hydroxypropionic acid;
L-3-Hydroxy-alanine;
Serine
Formula
C3H7NO3
Exact mass
105.0426
Mol weight
105.0926
Structure
Remark
Same as: D00016
Reaction
Pathway
map00260  Glycine, serine and threonine metabolism
map00261  Monobactam biosynthesis
map00270  Cysteine and methionine metabolism
map00460  Cyanoamino acid metabolism
map00600  Sphingolipid metabolism
map00630  Glyoxylate and dicarboxylate metabolism
map00680  Methane metabolism
map00920  Sulfur metabolism
map00970  Aminoacyl-tRNA biosynthesis
map00997  Biosynthesis of various secondary metabolites - part 3
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map01502  Vancomycin resistance
map02010  ABC transporters
map04071  Sphingolipid signaling pathway
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00020  Serine biosynthesis, glycerate-3P => serine
M00021  Cysteine biosynthesis, serine => cysteine
M00035  Methionine degradation
M00094  Ceramide biosynthesis
M00338  Cysteine biosynthesis, homocysteine + serine => cysteine
M00346  Formaldehyde assimilation, serine pathway
M00532  Photorespiration
M00736  Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A
M00785  Cycloserine biosynthesis, arginine/serine => cycloserine
M00875  Staphyloferrin B biosynthesis, L-serine => staphyloferrin B
Enzyme
1.1.1.276       1.1.1.387       1.4.1.7         2.1.2.1         
2.3.1.30        2.3.1.50        2.6.1.45        2.6.1.51        
2.7.1.80        2.7.1.225       2.7.1.226       2.7.8.4         
2.7.8.8         2.7.8.29        2.7.8.38        2.8.1.4         
3.1.3.3         3.1.4.13        3.5.1.61        4.2.1.20        
4.2.1.22        4.2.1.50        4.2.1.122       4.3.1.17        
4.3.1.19        5.1.1.10        5.1.1.18        6.1.1.11        
6.3.2.14
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00065  Serine (Ser)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00016  L-Serine
Other DBs
CAS: 56-45-1
PubChem: 3365
ChEBI: 17115
ChEMBL: CHEMBL11298
KNApSAcK: C00001393
PDB-CCD: SER[PDBj]
3DMET: B01145
NIKKAJI: J1.195I
KCF data

ATOM        7
            1   C1c C    23.5961  -17.5357
            2   C6a C    22.4445  -16.7873
            3   C1b C    24.8238  -16.8518
            4   N1a N    23.6370  -18.9388
            5   O6a O    21.2226  -17.4714
            6   O6a O    22.4677  -15.3785
            7   O1a O    26.0339  -17.5708
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1

» Japanese version

KEGG   COMPOUND: C00097
Entry
C00097                      Compound                               

Name
L-Cysteine;
L-2-Amino-3-mercaptopropionic acid
Formula
C3H7NO2S
Exact mass
121.0197
Mol weight
121.1582
Structure
Remark
Same as: D00026
Reaction
Pathway
map00260  Glycine, serine and threonine metabolism
map00270  Cysteine and methionine metabolism
map00311  Penicillin and cephalosporin biosynthesis
map00332  Carbapenem biosynthesis
map00430  Taurine and hypotaurine metabolism
map00460  Cyanoamino acid metabolism
map00480  Glutathione metabolism
map00730  Thiamine metabolism
map00770  Pantothenate and CoA biosynthesis
map00920  Sulfur metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map04122  Sulfur relay system
map04216  Ferroptosis
map04974  Protein digestion and absorption
map05230  Central carbon metabolism in cancer
Module
M00021  Cysteine biosynthesis, serine => cysteine
M00338  Cysteine biosynthesis, homocysteine + serine => cysteine
M00609  Cysteine biosynthesis, methionine => cysteine
M00672  Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin
M00673  Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C
Enzyme
1.8.1.6         1.8.1.9         1.8.1.10        1.8.3.5         
1.8.3.6         1.8.4.3         1.8.4.4         1.13.11.20      
1.14.14.43      1.14.14.45      1.14.99.51      1.14.99.52      
1.14.-.-        2.5.1.47        2.5.1.48        2.5.1.49        
2.5.1.65        2.6.1.1         2.6.1.3         2.8.1.4         
2.8.1.7         2.8.1.9         3.4.11.1        3.4.11.2        
3.4.11.23       3.4.13.-        3.13.1.6        4.2.1.22        
4.3.2.9         4.4.1.1         4.4.1.9         4.4.1.10        
4.4.1.13        4.4.1.28        5.1.1.10        6.1.1.16        
6.3.1.13        6.3.2.2         6.3.2.5         6.3.2.26        
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00097  Cysteine (Cys)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D00026  L-Cysteine (JP17)
Classification of Japanese OTC drugs [BR:br08313]
 Nourishing tonics and health supplements
  45 Protein and amino acid based drugs
   D00026  L-Cysteine (JP17)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Cysteine
    D00026  L-Cysteine (JP17)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00026  L-Cysteine
Other DBs
CAS: 52-90-4
PubChem: 3397
ChEBI: 17561
ChEMBL: CHEMBL863
KNApSAcK: C00001351
PDB-CCD: CYS[PDBj]
3DMET: B01159
NIKKAJI: J9.167G
KCF data

ATOM        7
            1   C1c C    24.5141  -15.4370
            2   C6a C    23.3459  -14.6895
            3   C1b C    25.7289  -14.7361
            4   N1a N    24.5609  -16.8388
            5   O6a O    22.1311  -15.3436
            6   O6a O    23.3459  -13.2877
            7   S1a S    26.9438  -15.4838
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1

» Japanese version

KEGG   COMPOUND: C00188
Entry
C00188                      Compound                               

Name
L-Threonine;
2-Amino-3-hydroxybutyric acid
Formula
C4H9NO3
Exact mass
119.0582
Mol weight
119.1192
Structure
Remark
Same as: D00041
Reaction
Pathway
map00260  Glycine, serine and threonine metabolism
map00261  Monobactam biosynthesis
map00290  Valine, leucine and isoleucine biosynthesis
map00860  Porphyrin and chlorophyll metabolism
map00970  Aminoacyl-tRNA biosynthesis
map00997  Biosynthesis of various secondary metabolites - part 3
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04974  Protein digestion and absorption
map04978  Mineral absorption
Module
M00018  Threonine biosynthesis, aspartate => homoserine => threonine
M00570  Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine
Enzyme
1.1.1.103       2.2.1.8         2.7.1.177       2.7.7.87        
3.4.-.-         4.1.2.5         4.1.2.48        4.2.3.1         
4.3.1.19        5.1.1.6         6.1.1.3         6.3.2.-
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00188  Threonine (Thr)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Threonine
    D00041  Threonine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00041  L-Threonine
Other DBs
CAS: 72-19-5
PubChem: 3488
ChEBI: 16857
ChEMBL: CHEMBL291747
KNApSAcK: C00001394
PDB-CCD: THR[PDBj]
3DMET: B01182
NIKKAJI: J21.883I
KCF data

ATOM        8
            1   O6a O    22.5407  -18.2704
            2   C6a C    23.7531  -17.5704
            3   C1c C    24.9657  -18.2704
            4   C1c C    26.1781  -17.5704
            5   C1a C    27.3906  -18.2704
            6   O6a O    23.7531  -16.1705
            7   N1a N    24.9657  -19.6703
            8   O1a O    26.1781  -16.1703
BOND        7
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     2   6 2
            6     3   7 1 #Down
            7     4   8 1 #Down

» Japanese version

KEGG   COMPOUND: C00064
Entry
C00064                      Compound                               

Name
L-Glutamine;
L-2-Aminoglutaramic acid
Formula
C5H10N2O3
Exact mass
146.0691
Mol weight
146.1445
Structure
Remark
Same as: D00015
Reaction
Pathway
map00220  Arginine biosynthesis
map00230  Purine metabolism
map00240  Pyrimidine metabolism
map00250  Alanine, aspartate and glutamate metabolism
map00471  D-Glutamine and D-glutamate metabolism
map00630  Glyoxylate and dicarboxylate metabolism
map00750  Vitamin B6 metabolism
map00910  Nitrogen metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01120  Microbial metabolism in diverse environments
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map02010  ABC transporters
map02020  Two-component system
map04724  Glutamatergic synapse
map04727  GABAergic synapse
map04964  Proximal tubule bicarbonate reclamation
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00048  Inosine monophosphate biosynthesis, PRPP + glutamine => IMP
M00051  Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP
M00916  Pyridoxal-P biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P
Enzyme
1.4.1.13        1.4.1.14        1.4.7.1         2.3.1.14        
2.3.1.68        2.3.2.1         2.3.2.14        2.4.2.14        
2.6.1.15        2.6.1.16        2.6.1.50        2.6.1.64        
2.6.1.85        2.6.1.86        2.6.1.100       2.6.1.101       
2.6.1.117       2.7.3.13        3.5.1.2         3.5.1.38        
3.5.1.133       4.1.3.27        4.3.2.10        4.3.3.6         
5.1.1.10        6.1.1.18        6.3.1.2         6.3.4.2         
6.3.5.1         6.3.5.2         6.3.5.3         6.3.5.4         
6.3.5.5         6.3.5.6         6.3.5.7         6.3.5.9         
6.3.5.10        6.3.5.11        6.3.5.12        6.3.5.13        
6.3.5.-
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00064  Glutamine (Gln)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AA Amino acids and derivatives
     A16AA03 Glutamine
      D00015  Glutamine (USP) <JP/US>
USP drug classification [BR:br08302]
 Gastrointestinal Agents
  Gastrointestinal Agents, Other
   Short Bowel Syndrome Agents
    Glutamine
     D00015  Glutamine (USP)
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
  Glutamine
   D00015  Glutamine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  23  Digestive organ agents
   232  Peptic ulcer agents
    2322  Glutamines
     D00015  Glutamine (USP); L-Glutamine (JP17)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Glutamine
    D00015  Glutamine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00015  L-Glutamine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D00015
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00015
Other DBs
CAS: 56-85-9
PubChem: 3364
ChEBI: 18050
ChEMBL: CHEMBL930
KNApSAcK: C00001359
PDB-CCD: GLN[PDBj]
3DMET: B00017
NIKKAJI: J9.170G
KCF data

ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2

» Japanese version

DBGET integrated database retrieval system